Tech Company Financing Transactions

Lava Therapeutics Funding Round

Lava Therapeutics, based in Utrecht, secured $83 million from Novo Ventures, Sanofi-Genzyme BioVentures and BB Pureos Bioventures.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

Yalelaan 60
Utrecht, 3584 CM
The Netherlands

Phone

+31 6 3000 3035

Website

www.lavatherapeutics.com

Email Address

[email protected]

Overview

Lava Therapeutics B.V. is a start-up biotechnology company, founded in 2016, that creates and develops next generation ?d T-cell engaging bispecific antibodies for the treatment of cancer. Our first-in-class immuno-oncology approach activates ?d T cells in a tumor target dependent manner.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Steve Hurly

        

Chief Marketing Officer

Benjamin Winograd

        

Chief Scientific Officer

Hans van der Vliet

        

VP - Bus. Development

Ton Adang

        

VP - R & D

Paul Parren

        

Browse more venture capital transactions:

Prev: 9/18/2020: Alloy venture capital transaction
Next: 9/18/2020: Cardea Bio venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary